Not applicableEnded earlyNCT02769000What this trial is testingLow Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer'sWho this might be right forAlzheimer's Disease Virginia Commonwealth University 5
Testing effectiveness (Phase 2)UnknownNCT02305836What this trial is testingEffect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's DiseaseWho this might be right forCognitive Impairment Guang'anmen Hospital of China Academy of Chinese Medical Sciences 334
Not applicableNot Yet RecruitingNCT07064382What this trial is testingVR-based Multi-dimensional Intervention on Cognitive Function, With AI-agentsWho this might be right forDementiaSleepinessMental Health+1 more Hong Kong University of Science and Technology 60
Testing effectiveness (Phase 2)Study completedNCT01227564What this trial is testingAmyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 63
Testing effectiveness (Phase 2)Study completedNCT00857506What this trial is testingObservational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)Who this might be right forAlzheimer's DiseaseMild Cognitive Impairment Avid Radiopharmaceuticals 152
Post-approval studies (Phase 4)Study completedNCT02190084What this trial is testingRepetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's DementiaWho this might be right forApathyAlzheimer's Dementia Central Arkansas Veterans Healthcare System 20
Post-approval studies (Phase 4)Study completedNCT00216515What this trial is testingThe Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer TypeWho this might be right forAlzheimer Disease Janssen Korea, Ltd., Korea 102
Large-scale testing (Phase 3)UnknownNCT00715858What this trial is testingA Pilot Study of Inflammatory Markers in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease McMaster University 21
Large-scale testing (Phase 3)Looking for participantsNCT07066826What this trial is testingClinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeWho this might be right forAlzheimer Dementia Wanbangde Pharmaceutical Group Co., LTD 720
Testing effectiveness (Phase 2)Study completedNCT01764243What this trial is testingSafety and Efficacy of MT-4666Who this might be right forAlzheimer's Disease Tanabe Pharma Corporation 450
Not applicableNot Yet RecruitingNCT07376135What this trial is testingLETHE-AT: a Personalized Multidomain Lifestyle Intervention for Individuals at Increased Risk of Memory Impairment.Who this might be right forMild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD) Medical University of Vienna 300
Not applicableStudy completedNCT05784298What this trial is testingAcute Effect of Low-intensity Gamma rTMS on Cognitive and EEG Parameters in Adults With Mild Dementia by Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseMild Dementia Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 27
Not applicableUnknownNCT05251649What this trial is testingTranscranial Alternating Current Stimulation Combined With 40Hz Sound Stimulation for Treatment Alzheimer's DiseaseWho this might be right forAlzheimer Disease Chinese PLA General Hospital 60
Large-scale testing (Phase 3)Study completedNCT00574132What this trial is testingBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)Who this might be right forAlzheimer's Disease JANSSEN Alzheimer Immunotherapy Research & Development, LLC 1,331
Very early researchStudy completedNCT01729598What this trial is testingValproic Acid in Subjects With Intact Cognition - Proof of Concept StudyWho this might be right forAlzheimer's Disease Gregory Jicha, 323-5550 14
Not applicableUnknownNCT03811184What this trial is testingValidation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreenWho this might be right forCognitive ImpairmentAlzheimer Disease MemScreen 400
Testing effectiveness (Phase 2)Ended earlyNCT03639987What this trial is testingAducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging AbnormalitiesWho this might be right forCognitive DysfunctionAlzheimer's Disease Biogen 52
Not applicableLooking for participantsNCT05980052What this trial is testingGoal Setting to Promote Physical Activity Adherence in Midlife AdultsWho this might be right forPhysical ActivityExercise Arizona State University 144
Not applicableUnknownNCT05655793What this trial is testingThe TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and DiagnosisWho this might be right forAlzheimer Disease Maastricht University Medical Center 200
Not applicableUnknownNCT03827733What this trial is testingGut Microbiota and Alzheimer's DiseasesWho this might be right forAlzheimer Disease Shanghai 10th People's Hospital 200